Companies

Onconetix, Inc.

ONCO · CIK 0001782107 · operating

$0.71+8.51%Last updated Mar 3, 6:00 PM

Key Statistics

Valuation

Market Cap$1.25M
P/E0.00
Fwd P/E-0.95
PEG
P/S1.02
P/B0.37
EV/EBITDA-0.07
EV/Rev0.28

Profitability

Gross Margin41.80%
Op. Margin-2237.96%
Net Margin-2325.21%
ROE-687.04%
ROA-208.26%
FCF Margin-416.95%

Financial Health

Current Ratio0.05
Debt/Equity2.17
Free Cash Flow-$10.52M
Div. Yield

Growth & Other

Revenue Growth4217.31%
EPS Growth-879.45%
Beta3.52
52W High$20.825
52W Low$0.62

About Onconetix, Inc.

Onconetix, Inc. (ONCO) is a pharmaceutical preparations company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1 million, Onconetix, Inc. is a micro-cap company. The stock currently trades at $0.71, up 8.51% today, with a 52-week range of $0.62–$28.05. The company trades at a trailing P/E of 0.0x.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2024$-21.45$-21.45-879.5%
2023$-2.19$-2.19-99.1%
2022$-1.10$-1.10

Annual Reports (10-K) · 4 filings

Report DateFiledAccession Number
2024-12-312025-06-020001213900-25-049687SEC ↗
2023-12-312024-04-110001213900-24-032225SEC ↗
2022-12-312023-03-090001213900-23-018635SEC ↗
2021-12-312022-03-310001213900-22-016672SEC ↗